Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Vyome Holdings, Inc./ 10-K

Annual Report · 10-K

Vyome Holdings, Inc.

HINDNASDAQEQUITYCurrent

Annual Report

Filed Apr 17, 2023Accepted Apr 17, 2023, 12:55 PM EDTCIK 1427570Accession 0001558370-23-006079
View company →Permanent SEC source ↗
Share

Company context

Vyome is building the world’s premier platform spanning the US-India innovation corridor. Vyome’s immediate focus is on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. By applying groundbreaking science and its unique positioning, Vyome seeks to deliver lasting value to shareholders in a hyper cost-efficient manner while upholding global standards of quality and safety.

Current securities

HINDNASDAQ · EQUITY · Current

Recent company filings

  1. 4 filingSep 3, 2026
  2. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsAug 28, 2026
  3. Results of Operations and Financial ConditionAug 25, 2026
  4. 10-Q filingAug 12, 2026
  5. Results of Operations and Financial ConditionMay 29, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗